As the Trump administration pushes to “Make America Healthy Again” and lays the groundwork for various reforms to American healthcare, it should set its sights on reforming the Food and Drug Administration’s evaluation processes. While the administration has recognized that novel technologies like artificial intelligence can fuel new medical breakthroughs, the FDA has shown that […]
Author Archives: Juan Londoño
Juan Londoño is the chief regulatory analyst at the Taxpayers Protection Alliance. He wrote this for InsideSources.com.
